These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28952)

  • 1. Initial potassium loss and hypokalaemia during chlorthalidone administration in patients with essential hypertension: the influence of dietary sodium restriction.
    Landmann-Suter R; Struyvenberg A
    Eur J Clin Invest; 1978 Jun; 8(3):155-64. PubMed ID: 28952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal dose of a thiazide diuretic.
    Carney S; Gillies AI; Morgan T
    Med J Aust; 1976 Oct; 2(18):692-3. PubMed ID: 796642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of sodium intake on hydrochlorothiazide-induced changes in blood pressure, serum electrolytes, renin and aldosterone in essential hypertension.
    van Brummelen P; Schalekamp M; de Graeff J
    Acta Med Scand; 1978; 204(3):151-7. PubMed ID: 696414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of the renal prostanoids to a short-term depletion of sodium or potassium in healthy women.
    Agnoli GC; Borgatti R; Cacciari M; Garutti C; Ikonomu E; Lenzi P; Marinelli M; Stipo L
    Boll Soc Ital Biol Sper; 1996; 72(3-4):109-16. PubMed ID: 8771911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuretic-induced hypokalemia and altered renal function.
    Carney SL; Morgan TO
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):665-7. PubMed ID: 3546168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chlorthalidone on serum and total body potassium in hypertensive patients.
    Leemhuis MP; van Damme KJ; Struyvenberg A
    Acta Med Scand; 1976; 200(1-2):37-45. PubMed ID: 8958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism underlying chlorthalidone-induced hypokalaemia: effects of sodium restriction, potassium suppletion, spironolactone, and triamterene.
    Haalboom JR; Struyvenberg A
    Neth J Med; 1982; 25(7):184-92. PubMed ID: 7144988
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
    Hunyor SN; Zweifler AJ; Hansson L; Schork MA; Ellis C
    Aust N Z J Med; 1975 Feb; 5(1):17-24. PubMed ID: 1057909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of potassium supplementation on markers of osmoregulation and volume regulation: results of a fully controlled dietary intervention study.
    Riphagen IJ; Gijsbers L; van Gastel MD; Kema IP; Gansevoort RT; Navis G; Bakker SJ; Geleijnse JM
    J Hypertens; 2016 Feb; 34(2):215-20. PubMed ID: 26599222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction.
    Gordon RD; Geddes RA; Pawsey CG; O'Halloran MW
    Australas Ann Med; 1970 Nov; 19(4):287-94. PubMed ID: 5490655
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
    Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
    JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease.
    Stewart DE; Ikram H; Espiner EA; Nicholls MG
    Br Heart J; 1985 Sep; 54(3):290-7. PubMed ID: 4041299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of long-term therapy with muzolimine and chlorthalidone in hypertension.
    Galletti F; Strazzullo P; Gagliardi R; Cirillo M; Siani A; Iacone R; Mancini M
    Eur J Clin Pharmacol; 1987; 33(5):515-7. PubMed ID: 3428346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.
    Vaughan ED; Laragh JH; Gavras I; Bühler FR; Gavras H; Brunner HR; Baer L
    Am J Cardiol; 1973 Sep; 32(4):523-32. PubMed ID: 4729722
    [No Abstract]   [Full Text] [Related]  

  • 15. Moderate sodium restriction and various diuretics in the treatment of hypertension.
    Ram CV; Garrett BN; Kaplan NM
    Arch Intern Med; 1981 Jul; 141(8):1015-9. PubMed ID: 7247587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total body potassium in patients receiving chlorthalidone and metoprolol for hypertension.
    Gray JM; Lawson DH; Boddy K; East W
    Scott Med J; 1983 Apr; 28(2):172-5. PubMed ID: 6867699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-aldosterone system and thiazide-induced depletion of total body potassium in essential hypertension.
    Oh MS; Carroll HJ
    Nephron; 1978; 21(5):269-76. PubMed ID: 714200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.
    Drayer JI; Kloppenborg PW; Festen J; van't Laar A; Benraad TJ
    Am J Cardiol; 1975 Oct; 36(5):716-21. PubMed ID: 1103606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention.
    Wylie-Rosett J; Wassertheil-Smoller S; Blaufox MD; Davis BR; Langford HG; Oberman A; Jennings S; Hataway H; Stern J; Zimbaldi N
    J Am Diet Assoc; 1993 Apr; 93(4):408-15. PubMed ID: 8454808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple method for definition of incomplete suppression of aldosterone and its association with hypertension and hypokalaemia in man.
    Adam WR
    Clin Sci (Lond); 1986 Oct; 71(4):375-83. PubMed ID: 3757436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.